HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 2,101-2,112 of 7,264
Drug study icon
CompletedNCT06267846

NBI-1070770 for depression

What is this study about?

Researchers compared NBI-1070770 and placebo to find out how the approaches affected depression symptoms in adults with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Little Rock
DepressionMedication studyAges 18–65
Countries
United States
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
CompletedNCT06372210

A study to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Official study title

An Open-label, Prospective Trial Assessing Positive Detection Accuracy and Detection Latency Measures of the Miniature Ingestible Event Marker Tablet Using the D-Tect Patch in Healthy Subjects and Assessing Detection Latency Measures Using the D-Tect Patch in Subjects With Serious Mental Illness Taking Abilify MyCite Tablet

This study has finished and is no longer accepting participants.

In Garden Grove
Depression, Schizophrenia, ...Medication studyAges 18+
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Device study icon
UnknownNCT05384405

aiTBS for Relieving NSSI in Depressive Patients

Official study title

Accelerated Intermittent Theta Burst Stimulation for the Treatment of Non-suicidal Self-injury in Patients With Unipolar Depression and Bipolar Depression: a Sham-controlled Study

Current recruitment status is unconfirmed.

In Changsha
Depression, BipolarityDevice studyAges 12–18
Countries
China
Sponsor
Central South University
Device study icon
UnknownNCT06452849

Amygdala and dLPFC MRI-TIS for Depression in Adolescents

Official study title

Temporal Interference Stimulation of Amygdala and dLPFC: A Randomized Controlled Trial for Adolescent Depression

Current recruitment status is unconfirmed.

In Shanghai
DepressionDevice studyAges 14–18
Countries
China
Sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Device study icon
UnknownNCT06461260

Amygdala MRI-TIS for Depression

Official study title

Safety, Efficacy and Neuroimaging Mechanisms of Amygdala Temporal Interference Stimulation Therapy for Depression

Current recruitment status is unconfirmed.

In Shanghai
DepressionDevice studyAges 18–65
Countries
China
Sponsor
Shanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University
Device study icon
CompletedNCT06477276

Amygdala TIS for Depression

Official study title

A Multicenter, Randomized, Controlled, Double-Blind Trial on the Efficacy and Safety of Amygdala Temporal Interference Stimulation for the Treatment of Depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Shanghai
DepressionDevice studyAges 18–65
Countries
China
Sponsor
Ruijin Hospital
Drug study icon
Active Not RecruitingNCT06922110

An Study of Azetukalner in Major Depressive Disorder

What is this study about?

Researchers are studying Azetukalner, tracking side effects to assess long-term safety and tolerability in people with depression.

This study is no longer accepting new participants.

Multiple locations, including Phoenix
DepressionMedication studyAges 18+
Countries
United States, Finland, Poland
Sponsor
Xenon Pharmaceuticals Inc.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.